ALMR vs AMIX

Alamar Biosciences, Inc. vs Autonomix Medical, Inc. — Valuation Comparison 2026

ALMR

Medical Devices
Alamar Biosciences, Inc.
Quality
1.7
out of 10
Value Trap
Price
$20.44
Last close
Models
8/13
Active
VS

AMIX

Medical Devices
Autonomix Medical, Inc.
Quality
4.3
out of 10
Value Trap
Price
$0.40
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType ALMR Fair ValueALMR Upside AMIX Fair ValueAMIX Upside
Bayesian DCF Intrinsic $5.41 -73.5% $0.58 +46.0%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $14.24 -30.3% $1.10 +173.8%
PWERM Option-Based $22.30 +9.1% $0.52 +29.7%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ALMR vs AMIX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ALMR vs AMIX — Which Stock Is More Undervalued?

AMIX scores higher with a 4.3/10 quality rating vs ALMR's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Alamar Biosciences, Inc. (ALMR) and Autonomix Medical, Inc. (AMIX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ALMR currently trades at $20.44 with a QOC of 1.7/10, while AMIX trades at $0.40 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).